Divi's Laboratories Limited
DIVISLAB
株式のランク
#896
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India,... Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
株価
$100.92
時価総額
$26.79B
変化（1日）
0.63%
変化（1年）
34.86%
国
IN
取引 Divi's Laboratories Limited (DIVISLAB)
カテゴリー
Healthcare
Divi's Laboratories Limited（DIVISLAB）の収益
Jun 2026 時点の収益 TTM: $1.24B
Divi's Laboratories Limited の最新の財務報告によると、現在の収益 (TTM) は $1.24B です。2024 年には $934.96M の収益があり、これは 2023 年の $942.90M と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Divi's Laboratories Limited の収益履歴（2005 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $1.24B | 13.27% |
| 2025 | $1.09B | 17.03% |
| 2024 | $934.96M | -0.84% |
| 2023 | $942.90M | -18.66% |
| 2022 | $1.16B | 23.73% |
| 2021 | $936.88M | 33.39% |
| 2020 | $702.35M | 0.99% |
| 2019 | $695.47M | 16.36% |
| 2018 | $597.68M | -4.38% |
| 2017 | $625.04M | 9.65% |
| 2016 | $570.02M | 14.19% |
| 2015 | $499.20M | 18.17% |
| 2014 | $422.45M | 7.02% |
| 2013 | $394.74M | 7.38% |
| 2012 | $367.61M | 24.43% |
| 2011 | $295.42M | 40.91% |
| 2010 | $209.66M | -9.82% |
| 2009 | $232.50M | -90.99% |
| 2008 | $2.58B | 1,444.12% |
| 2007 | $167.15M | 95.34% |
| 2006 | $85.57M | 7.56% |
| 2005 | $79.55M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 433.49% |
IN
|
